Kinesin KIF4A is associated with chemotherapeutic drug resistance by regulating intracellular trafficking of lung resistance-related protein

J Zhejiang Univ Sci B. 2017;18(12):1046-1054. doi: 10.1631/jzus.B1700129.

Abstract

Multidrug resistance (MDR) is the major impediment to cancer chemotherapy. The expression of lung resistance-related protein (LRP), a non-ATP-binding cassette (ABC) transporter, is high in tumor cells, resulting in their resistance to a variety of cytotoxic drugs. However, the function of LRP in tumor drug resistance is not yet explicit. Our previous studies had shown that Kinesin KIF4A was overexpressed in cisplatin (DDP)-resistant human lung adenocarcinoma cells (A549/DDP cells) compared with A549 cells. The expression of KIF4A in A549 or A549/DDP cells significantly affects cisplatin resistance but the detailed mechanisms remain unclear. Here, we performed co-immunoprecipitation experiments to show that the tail domain of KIF4A interacted with the N-terminal of LRP. Immunofluorescence images showed that both the ability of binding to LRP and the motility of KIF4A were essential for the dispersed cytoplasm distribution of LRP. Altogether, our results shed light on a potential mechanism in that motor protein KIF4A promotes drug resistance of lung adenocarcinoma cells through transporting LRP-based vaults along microtubules towards the cell membrane. Thus KIF4A might be a cisplatin resistance-associated protein and serves as a potential target for chemotherapeutic drug resistance in lung cancer.

Keywords: KIF4A; Lung resistance-related protein (LRP); Drug resistance.

MeSH terms

  • A549 Cells
  • Antineoplastic Agents / pharmacology*
  • Cisplatin / pharmacology
  • Cytoplasm / metabolism
  • Drug Resistance, Neoplasm*
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Kinesins / metabolism*
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / metabolism
  • Microscopy, Fluorescence
  • Microtubules / metabolism
  • Protein Domains
  • Protein Transport
  • RNA, Small Interfering / metabolism
  • Vault Ribonucleoprotein Particles / metabolism*

Substances

  • Antineoplastic Agents
  • RNA, Small Interfering
  • Vault Ribonucleoprotein Particles
  • major vault protein
  • KIF4A protein, human
  • Kinesins
  • Cisplatin